Author Profile
Xu, Chong
The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights
Matos, Pedro Aleyev, Dmitriy Xu, Chong
F-1715 | Published October 22, 2014 | 16 pages Case
Collection: Darden School of Business
This case is designed for MBA students in M&A or derivatives courses. In January 2011, Sanofi-Aventis was finalizing its offer terms for acquiring Genzyme. The M&A valuation disputes were about the ma... Read More
Sanofi-Aventis's Tender Offer for Genzyme
Eades, Kenneth M. Matos, Pedro Aleyev, Dmitriy Xu, Chong
F-1716 | Published October 22, 2014 | 24 pages Case
Collection: Darden School of Business
In October 2010, Henri Termeer, the chairman and CEO of Genzyme, received a letter from the CEO of Sanofi-Aventis announcing its intention to commence a tender offer for Genzyme. Termeer thought the o... Read More